Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Ingresos
702
591
492
410
322
265
Crecimiento de los Ingresos (YoY)
25%
20%
20%
27%
22%
24%
Costo de los ingresos
208
184
160
129
109
70
Utilidad bruta
494
407
331
281
213
194
Venta, General y Administración
465
407
369
322
274
197
Investigación y Desarrollo
82
71
60
46
38
41
Gastos de Operación
548
478
430
368
313
238
Otras Ingresos (Gastos) No Operativos
4
1
6
2
0
1
Ingreso antes de impuestos
-50
-112
-122
-115
-101
-43
Gasto por Impuesto a la Renta
0
0
0
0
0
0
Ingreso Neto
-51
-113
-123
-116
-101
-43
Crecimiento de la Utilidad Neta
-66%
-8%
6%
15%
135%
-20%
Acciones en Circulación (Diluidas)
32.17
31.19
30.52
29.9
29.3
27.8
Cambio de Acciones (YoY)
3%
2%
2%
2%
5%
10%
EPS (Diluido)
-1.59
-3.63
-4.04
-3.88
-3.46
-1.58
Crecimiento de EPS
-67%
-10%
4%
12%
119%
-27%
Flujo de efectivo libre
32
-45
-90
-52
-65
-27
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
70.37%
68.86%
67.27%
68.53%
66.14%
73.2%
Margen de operación
-7.54%
-12.01%
-19.91%
-21.21%
-30.74%
-16.22%
Margen de beneficio
-7.26%
-19.12%
-25%
-28.29%
-31.36%
-16.22%
Margen de flujo de caja libre
4.55%
-7.61%
-18.29%
-12.68%
-20.18%
-10.18%
EBITDA
-33
-51
-82
-74
-90
-37
Margen de EBITDA
-4.7%
-8.62%
-16.66%
-18.04%
-27.95%
-13.96%
D&A para EBITDA
20
20
16
13
9
6
EBIT
-53
-71
-98
-87
-99
-43
Margen de EBIT
-7.54%
-12.01%
-19.91%
-21.21%
-30.74%
-16.22%
Tasa de Impuesto Efectiva
0%
0%
0%
0%
0%
0%
Estadísticas clave
Cierre Anterior
$148.41
Precio de apertura
$148.42
Rango del día
$143.94 - $150.29
Rango de 52 semanas
$92.52 - $212
Volumen
455.3K
Volumen promedio
523.4K
EPS (TTM)
-1.62
Rendimiento de dividendos
--
Cap. de mercado
$4.6B
¿Qué es IRTC?
iRhythm Holdings, Inc. is a digital healthcare company, which engages in the provision of design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. The company is headquartered in San Francisco, California and currently employs 2,000 full-time employees. The company went IPO on 2016-10-20. The company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. The company offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. The company offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry (MCT) monitoring services, using its Zio Systems. The Zio Monitor System is a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for over 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.